AVMXY nano cap $30.17 Million OTC $1.42
Post# of 63688
nano cap $30.17 Million
OTC $1.42
Avita Medical Signs Distributor Deal
With China's Largest Healthcare Group
Marketwired (Thu, Mar 10)
Website
Shares Outstanding: 21.25M
Float: 19.71M
% Held by Insiders1: N/A
% Held by Institutions1: N/A
Recent Trades
StockWatch
Headlines
Avita Medical develops and distributes regenerative and tissue-engineered products for the human body to treat a range of wounds, scars, and skin in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. Its lead product is ReCell Spray-On Skin used in various burns, plastic, reconstructive, and cosmetic procedures. The company also manufactures and sells a range of spacers, including Funhaler incentive asthma spacer for the paediatric market; and Breath-A-Tech spacer for the adolescent and adult markets. Avita Medical Limited is headquartered in Royston, the United Kingdom.